CG Add to watchlist $46.07 0.56 (-1.20%) Last updated: Jul 19, 2026 11:25
52-Week Range
$46.07
$39.60 $46.07 $69.85

Fundamentals Overview

The Carlyle Group Inc. is near the low of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 30.3 P/B 3.06 P/S 4.16

Intrinsic value (DCF)

-33.7% downside vs price

Profitability

Net margin 13.7%

Risk (Beta)

1.83 — higher vol

Earnings & growth

EPS $1.52 Rev -89.7% Profit -136.9% vs prior qtr

BullzEye Analysis

Our composite tilts Sell on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Sell — 84% confidence Risk: High Volatility — Beta 1.83. Consider smaller position size due to higher beta.

Pressures (Sell):

DCF 33.7% downside vs price · Sentiment weakening (1 downgrade) · 3M vs S&P 500: -17.7% · 3M vs Financial Services sector: -19.3% · Beta 1.83 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$16.58B
P/E (TTM)
30.28
EPS (TTM)
$1.52
Dividend Yield
3.04%
52-Week Range
$39.60 - $69.85
Volume vs Avg
N/A
Beta
1.83

About

The Carlyle Group Inc. is a leading global investment firm that employs both direct investment and fund-of-fund strategies. Its direct investment expertise is extensive, encompassing management-led leveraged buyouts, privatizations, and divestitures, as well as strategic minority equity investments. The firm also allocates capital to structured credit opportunities, global distressed and corporate situations, and small-to-middle market enterprises. Its venture and growth capital activities span ...
Sector: Financial Services
Headquarters: US
Employees: 2,500
IPO Date: May 2012
Beta: 1.83 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: C. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 7, Equal Weight: 1, Hold: 2, In Line: 4, Market Outperform: 1, Market Perform: 1, Neutral: 4, Outperform: 2, Overweight: 7, Sector Perform: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $30.54; current price is $46.07. That’s a -33.7% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 30.28
DCF value (model) $30.54 (-33.7% vs price)
PEG (TTM) N/A
P/B (TTM) 3.06
P/S (TTM) 4.16
Liquidity & enterprise
Current Ratio (TTM) 10.83
Quick Ratio (TTM) 10.83
Cash Ratio (TTM) 7.69
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 13.7%
Gross margin (TTM) 73.08%
Operating margin (TTM) 22.21%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for CG.

Analyst Sentiment at a Glance

C Sentiment Weakening
Buy 7Equal Weight 1Hold 2In Line 4Market Outperform 1Market Perform 1Neutral 4Outperform 2Overweight 7Sector Perform 1
0 upgrades, 1 downgrade
Price Target Consensus
Current $46.07
Median $56.50
Consensus $56.50
Low consensus $45.00
High consensus $71.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Evercore ISI Group maintain In Line In Line 2026-07-13
RBC Capital maintain Sector Perform Sector Perform 2026-07-13
Barclays maintain Overweight Overweight 2026-07-09
Citizens maintain Market Outperform Market Outperform 2026-07-09
TD Cowen maintain Hold Hold 2026-05-18
TD Cowen downgrade Buy Hold 2026-05-08
Barclays maintain Overweight Overweight 2026-05-08
JP Morgan maintain Neutral Neutral 2026-05-08
JP Morgan maintain Neutral Neutral 2026-04-30
Evercore ISI Group maintain In Line In Line 2026-04-21
Morgan Stanley maintain Equal Weight Equal Weight 2026-04-21
Barclays maintain Overweight Overweight 2026-04-08
Goldman Sachs maintain Buy Buy 2026-04-07
BMO Capital maintain Outperform Outperform 2026-03-24
Barclays maintain Overweight Overweight 2026-03-02
RBC Capital maintain Outperform Outperform 2026-02-27
TD Cowen maintain Buy Buy 2026-02-27
UBS maintain Buy Buy 2026-02-20
JP Morgan maintain Neutral Neutral 2026-02-10
Barclays maintain Overweight Overweight 2026-02-09
Evercore ISI Group maintain In Line In Line 2026-01-22
TD Cowen maintain Buy Buy 2026-01-14
UBS maintain Buy Buy 2026-01-13
Barclays maintain Overweight Overweight 2025-12-15
Barclays maintain Overweight Overweight 2025-12-12
Keefe, Bruyette & Woods maintain Market Perform Market Perform 2025-11-03
TD Cowen maintain Buy Buy 2025-11-03
Citigroup maintain Buy Buy 2025-11-03
Evercore ISI Group maintain In Line In Line 2025-11-03
JP Morgan maintain Neutral Neutral 2025-11-03